John Oyler is Co-Founder, Chairman and Chief Executive Officer of BeOne Medicines Ltd. (ONC). The company reported total compensation of $17,943,521 for fiscal year 2025.
| Salary | $1,133,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $11,249,615 |
| Option awards | $3,749,967 |
| Non-equity incentive plan | $1,676,840 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $133,829 |
| Total | $17,943,521 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure BeOne Medicines Ltd. filed April 28, 2026, accession 0001104659-26-049655.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Co-Founder, Chairman and Chief Executive Officer | $1,133,000 | $0 | $11,249,615 | $3,749,967 | $1,676,840 | $0 | $133,829 | $17,943,521 |
| FY2024 | Co-Founder, Chairman and Chief Executive Officer | $1,100,000 | $0 | $11,999,768 | $5,999,924 | $1,540,000 | $0 | $196,747 | $20,836,439 |
| FY2023 | Co-Founder, Chairman and Chief Executive Officer | $871,000 | $0 | $5,499,851 | $10,999,987 | $1,132,300 | $0 | $403,692 | $18,906,830 |
Totals as disclosed in each year's own compensation disclosure for BeOne Medicines Ltd..
| Peer-group chief executive median | $20,538,239 |
|---|---|
| Difference from that median | $-2,594,718 |
| Percentile within the disclosed peer group | 29th |
| Peers with a disclosed figure | 14 |
Medians and percentiles are computed across the peer group BeOne Medicines Ltd. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Lai Wang | President, Global Head of Research and Development | $18,319,310 |
| John Oyler this page | Co-Founder, Chairman and Chief Executive Officer | $17,943,521 |
| Xiaobin Wu | President and Chief Operating Officer | $12,029,451 |
| Aaron Rosenberg | Chief Financial Officer | $6,428,374 |
| Chan Lee | Senior Vice President, General Counsel and Corporate Secretary | $5,055,306 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full BeOne Medicines Ltd. compensation brief.
John Oyler's compensation sits inside BeOne Medicines Ltd.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.